Related references
Note: Only part of the references are listed.A Hardwired HIV Latency Program
Brandon S. Razooky et al.
CELL (2015)
HIV therapeutic vaccines: moving towards a functional cure
Geetha H. Mylvaganam et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
Guillaume Mousseau et al.
MBIO (2015)
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues
Courtney V. Fletcher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Triptolide inhibits human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat protein
Zhitao Wan et al.
RETROVIROLOGY (2014)
Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy
Mary F. Kearney et al.
PLOS PATHOGENS (2014)
Blocking HIV-1 Replication by Targeting the Tat-Hijacked Transcriptional Machinery
Serena Massari et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Increase in 2-Long Terminal Repeat Circles and Decrease in D-dimer After Raltegravir Intensification in Patients With Treated HIV Infection: A Randomized, Placebo-Controlled Trial
Hiroyu Hatano et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Cellular and molecular mechanisms involved in the establishment of HIV-1 latency
Daniel A. Donahue et al.
RETROVIROLOGY (2013)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Saez-Cirion et al.
PLOS PATHOGENS (2013)
An Analog of the Natural Steroidal Alkaloid Cortistatin A Potently Suppresses Tat-Dependent HIV Transcription
Guillaume Mousseau et al.
CELL HOST & MICROBE (2012)
The Viral Protein Tat Can Inhibit the Establishment of HIV-1 Latency
Daniel A. Donahue et al.
JOURNAL OF VIROLOGY (2012)
Towards an HIV cure: a global scientific strategy
Steven G. Deeks
NATURE REVIEWS IMMUNOLOGY (2012)
The Control of HIV Transcription: Keeping RNA Polymerase II on Track
Melanie Ott et al.
CELL HOST & MICROBE (2011)
HIV reservoirs and the possibility of a cure for HIV infection
S. Palmer et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Celastrol Inhibits Tat-Mediated Human Immunodeficiency Virus (HIV) Transcription and Replication
Vivek Narayan et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Scalable Synthesis of Cortistatin A and Related Structures
Jun Shi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit
Jonathan Karn
CURRENT OPINION IN HIV AND AIDS (2011)
15-Deoxy-Δ12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification
Parisa Kalantari et al.
FASEB JOURNAL (2009)
Modeling HIV persistence, the latent reservoir, and viral blips
Libin Rong et al.
JOURNAL OF THEORETICAL BIOLOGY (2009)
Latently-infected CD4+T cells are enriched for HIV-1 Tat variants with impaired transactivation activity
Steven Yukl et al.
VIROLOGY (2009)
The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter
Tokameh Mahmoudi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cortistatins A, B, C, and D, anti-angiogenic steroidal alkaloids, from the marine sponge Corticium simplex
S Aoki et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Share Paper
